Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash from Financing Activities (2019 - 2026)

Outset Medical has reported Cash from Financing Activities over the past 7 years, most recently at $231000.0 for Q3 2025.

  • Quarterly Cash from Financing Activities rose 90.91% to $231000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $55.5 million through Dec 2025, down 18.22% year-over-year, with the annual reading at $55.5 million for FY2025, 18.22% down from the prior year.
  • Cash from Financing Activities was $231000.0 for Q3 2025 at Outset Medical, up from -$384000.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $150.8 million in Q2 2021 and troughed at -$938000.0 in Q4 2024.
  • The 5-year median for Cash from Financing Activities is $2.5 million (2022), against an average of $21.1 million.
  • Year-over-year, Cash from Financing Activities soared 558448.15% in 2021 and then crashed 598.7% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $934000.0 in 2021, then surged by 6923.55% to $65.6 million in 2022, then tumbled by 49.35% to $33.2 million in 2023, then tumbled by 102.82% to -$938000.0 in 2024, then soared by 124.63% to $231000.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash from Financing Activities are $231000.0 (Q3 2025), -$384000.0 (Q2 2025), and $55.7 million (Q1 2025).